You do not have permission to edit this page, for the following reasons:

This IP address has been blocked from editing Wikipedia.
This does not affect your ability to read Wikipedia pages.
Most people who see this message have done nothing wrong. Some kinds of blocks restrict editing from specific service providers or telecom companies in response to recent abuse or vandalism, and can sometimes affect other users who are unrelated to that abuse. Review the information below for assistance if you do not believe that you have done anything wrong.

The IP address or range 54.163.0.0/16 has been blocked (disabled) by ‪Blablubbs‬ for the following reason(s):

The IP address that you are currently using has been blocked because it is believed to be a web host provider or colocation provider. To prevent abuse, web hosts and colocation providers may be blocked from editing Wikipedia.
You will not be able to edit Wikipedia using a web host or colocation provider because it hides your IP address, much like a proxy or VPN.
We recommend that you attempt to use another connection to edit. For example, if you use a proxy or VPN to connect to the internet, turn it off when editing Wikipedia. If you edit using a mobile connection, try using a Wi-Fi connection, and vice versa. If you are using a corporate internet connection, switch to a different Wi-Fi network. If you have a Wikipedia account, please log in.
If you do not have any other way to edit Wikipedia, you will need to request an IP block exemption.

How to appeal if you are confident that your connection does not use a colocation provider's IP address:
If you are confident that you are not using a web host, you may appeal this block by adding the following text on your talk page: ((unblock|reason=Caught by a colocation web host block but this host or IP is not a web host. My IP address is _______. Place any further information here. ~~~~)). You must fill in the blank with your IP address for this block to be investigated. Your IP address can be determined here. Alternatively, if you wish to keep your IP address private you can use the unblock ticket request system. There are several reasons you might be editing using the IP address of a web host or colocation provider (such as if you are using VPN software or a business network); please use this method of appeal only if you think your IP address is in fact not a web host or colocation provider.

Administrators: The IP block exemption user right should only be applied to allow users to edit using web host in exceptional circumstances, and requests should usually be directed to the functionaries team via email. If you intend to give the IPBE user right, a CheckUser needs to take a look at the account. This can be requested most easily at SPI Quick Checkuser Requests. Unblocking an IP or IP range with this template is highly discouraged without at least contacting the blocking administrator.

This block will expire on 17:28, 10 March 2024.

Even when blocked, you will usually still be able to edit your user talk page, as well as email administrators and other editors.

For information on how to proceed, please read the FAQ for blocked users and the guideline on block appeals. The guide to appealing blocks may also be helpful.

Other useful links: Blocking policy · Help:I have been blocked
Your IP address is in a range that has been blocked on all Wikimedia Foundation wikis. The block was made by ‪Jon Kolbert‬. The reason given is Open proxy/Webhost: See the help page if you are affected .
- Start of block: 18:27, 12 November 2023
- Expiry of block: 18:27, 12 November 2028
Your current IP address is 54.163.179.242. The blocked range is 54.163.0.0/16. Please include all above details in any queries you make. If you believe you were blocked by mistake, you can find additional information and instructions in the No open proxies global policy. Otherwise, to discuss the block please post a request for review on Meta-Wiki. You could also send an email to the stewards VRT queue at stewards@wikimedia.org including all above details.

You can view and copy the source of this page:

((More citations needed|date=August 2013))
((Infobox company
| logo =   GambroAK200.jpg
| type   = Business unit of [[Baxter International]].
| industry       = Healthcare
| location       = [[Deerfield, Illinois]], U.S.
| num_employees  = approx. 7,500 
| foundation     = 1964 in Lund by [[Holger Crafoord]]
| homepage       = [http://www.gambro.com/ www.gambro.com]
| parent         = [[Baxter International]]

))

'''Gambro''' is a global medical technology company that manufactures products for [[Kidney dialysis|dialysis]] treatment. The company is involved in developing, manufacturing and supplying products and therapies for kidney
and liver dialysis, ((clarify span|myeloma kidney therapy|date=June 2019)), and other extracorporeal therapies for chronic and acute patients. Gambro was founded in [[Lund]], [[Sweden]], in 1964 by Holger Crafoord and has around 8,000 employees, production facilities in nine countries, and sales in more than 100 countries.<ref name="About Gambro">((Cite web|url=http://www.gambro.com/en/usa/About-Gambro/Gambro-in-brief/|title=About Gambro|accessdate=December 11, 2014|publisher=Gambro|year=2014|author=Gambro))</ref>

In September 2013, Baxter International completed its acquisition of Gambro.<ref name="Gambro Acquisition">((Cite web|url=http://www.baxter.com/press_room/press_releases/2013/09_06_13_gambro.html|title=Baxter Acquires Gambro|accessdate=December 11, 2014|publisher=Baxter|year=2013|author=Baxter))</ref>

== History ==
Professor [[Nils Alwall]] invented one of the first artificial kidneys in 1961. Three years later he met industrialist and businessman [[Holger Crafoord]], who was impressed by Alwall's invention and felt compelled to develop and market this life-saving innovation.<ref name="lund">((Cite web|url=http://www.med.lu.se/english/about_the_faculty/faculty_milestones/nils_alwall|title=Nils Alwall, the artificial kidney and Gambro|accessdate=December 11, 2014|publisher=Lund University|year=2005|author=Lund University|url-status=dead|archiveurl=https://web.archive.org/web/20071001215324/http://www.med.lu.se/english/about_the_faculty/faculty_milestones/nils_alwall|archivedate=October 1, 2007))</ref>

The development of single-use artificial kidneys began in [[Lund]], [[Sweden]], and mass production started in 1967 with the "Ad-modum-Alwall" dialyzer. The company adopted the name Gambro, which is the abbreviation of the original Swedish company name: ((Lang|sv|Gamla Brogatans Sjukvårdsaffär Aktiebolag|italic=no)). Roughly translated, this means 'The Old Bridge Street Medical Supplies Company'. The company's first plant outside Sweden was built in [[Hechingen]], [[Germany]], in the 1970s. In 1983, Gambro was listed on the Stockholm Stock Exchange. On 3 April 2006, Indap AB, joint owned by Swedish investment companies EQT and [[Investor AB]], announced a public cash offer to the shareholders of Gambro to acquire all outstanding shares in the company. The new ownership structure of Gambro became effective in June 2006.<ref name="lund"/>

In recent decades, Gambro's range of products and therapies has grown — through the introduction of new products, as well as several acquisitions, such as Hospal in 1987, COBE in 1990, Teraklin in 2004, and the latest addition of CHF Solutions Inc. in 2010. CHF Solutions designs and manufactures therapies and products for treating fluid overload by means of [[ultrafiltration]].<ref name="Aquadex">((Cite web|url=http://www.gambro.com/en/global/Products/Acute-Care/Acute-Monitors/Aquadex-FlexFlow/|title=Aquadex FlexFlow|accessdate=December 11, 2014|publisher=Gambro|year=2014|author=Gambro))</ref>

In July 2013, [[Baxter International]]'s bid for Gambro was approved by EU antitrust regulators.<ref>((cite news| url=https://www.reuters.com/article/us-baxterinternational-gambro-eu-idUSBRE9690ML20130710| title=EU to clear Baxter's $4 billion buy of Sweden's Gambro: sources | author=Foo Yun Chee | publisher=Reuters | date=10 July 2013))</ref>

== Organization ==
Gambro has production facilities in nine countries. The company's newest plant is a manufacturing facility in [[Opelika]], Alabama, USA which started production in 2009.<ref name="Opelika Expansion">((Cite web|url=http://www.oanow.com/news/opelika/article_75a00b36-2886-11e4-a360-001a4bcf6878.html|title=Opelika|accessdate=December 11, 2014|publisher=Opelika-Auburn News|year=2014|author=Sara Falligant))</ref> The largest manufacturing facility is located in Hechingen, Germany, employing approximately 1,380 people.
Gambro has 350 research and development employees in four locations all over Europe.((citation needed|date=January 2022))
The company has offices and representatives in more than 100 countries. Around 350,000 chronic renal disease patients are treated with Gambro products every year; this is approximately one quarter of all dialysis patients worldwide.((citation needed|date=January 2022))

== References ==
((reflist))

[[Category:1964 establishments in Sweden]]
[[Category:Health care companies established in 1964]]
[[Category:Health care companies of Sweden]]
[[Category:Baxter International]]
[[Category:Companies based in Lund]]
[[Category:2006 mergers and acquisitions]]
[[Category:2013 mergers and acquisitions]]

Pages transcluded onto the current version of this page (help):

Gambro (edit)
Template:Ambox (view source) (template editor protected)
Template:Category handler (view source) (protected)
Template:Citation needed (view source) (protected)
Template:Cite news (view source) (protected)
Template:Cite web (view source) (protected)
Template:Clarify span (view source) (semi-protected)
Template:Comma separated entries (view source) (template editor protected)
Template:Delink (view source) (protected)
Template:Find sources mainspace (view source) (template editor protected)
Template:Fix (view source) (protected)
Template:Fix-span (view source) (template editor protected)
Template:Fix/category (view source) (protected)
Template:Infobox (view source) (template editor protected)
Template:Infobox company (view source) (template editor protected)
Template:Lang (view source) (template editor protected)
Template:Longitem (view source) (template editor protected)
Template:Main other (view source) (protected)
Template:More citations needed (view source) (template editor protected)
Template:PAGENAMEBASE (view source) (template editor protected)
Template:Reflist (view source) (protected)
Template:Reflist/styles.css (view source) (protected)
Template:Template other (view source) (protected)
Module:Arguments (view source) (protected)
Module:Category handler (view source) (protected)
Module:Category handler/blacklist (view source) (protected)
Module:Category handler/config (view source) (protected)
Module:Category handler/data (view source) (protected)
Module:Category handler/shared (view source) (protected)
Module:Check for clobbered parameters (view source) (template editor protected)
Module:Check for unknown parameters (view source) (protected)
Module:Citation/CS1 (view source) (protected)
Module:Citation/CS1/COinS (view source) (protected)
Module:Citation/CS1/Configuration (view source) (protected)
Module:Citation/CS1/Date validation (view source) (protected)
Module:Citation/CS1/Identifiers (view source) (protected)
Module:Citation/CS1/Utilities (view source) (protected)
Module:Citation/CS1/Whitelist (view source) (protected)
Module:Citation/CS1/styles.css (view source) (protected)
Module:DecodeEncode (view source) (template editor protected)
Module:Delink (view source) (protected)
Module:Find sources (view source) (template editor protected)
Module:Find sources/config (view source) (template editor protected)
Module:Find sources/links (view source) (template editor protected)
Module:Find sources/templates/Find sources mainspace (view source) (template editor protected)
Module:Infobox (view source) (template editor protected)
Module:Infobox/styles.css (view source) (template editor protected)
Module:InfoboxImage (view source) (template editor protected)
Module:Lang (view source) (template editor protected)
Module:Lang/ISO 639 synonyms (view source) (template editor protected)
Module:Lang/data (view source) (template editor protected)
Module:Language/data/iana languages (view source) (template editor protected)
Module:Language/data/iana regions (view source) (template editor protected)
Module:Language/data/iana scripts (view source) (template editor protected)
Module:Language/data/iana suppressed scripts (view source) (template editor protected)
Module:Language/data/iana variants (view source) (template editor protected)
Module:Message box (view source) (protected)
Module:Message box/ambox.css (view source) (protected)
Module:Message box/configuration (view source) (protected)
Module:Namespace detect/config (view source) (protected)
Module:Namespace detect/data (view source) (protected)
Module:Separated entries (view source) (protected)
Module:String (view source) (protected)
Module:TableTools (view source) (protected)
Module:Unicode data (view source) (template editor protected)
Module:Unsubst (view source) (protected)
Module:WikidataIB (view source) (template editor protected)
Module:WikidataIB/nolinks (view source) (template editor protected)
Module:WikidataIB/titleformats (view source) (template editor protected)
Module:Yesno (view source) (protected)

Return to Gambro.

Retrieved from "https://en.wikipedia.org/wiki/Gambro"